4
Changes in Ownership
Lexaria Bioscience Corp. Filed Acc 0001348362-20-000004
Options or other derivatives
- Chief Financial Officer disposed of 650,000 shares (other)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Spissinger Allan Horst Chief Financial Officer | 2020-03-23 | Other disposition · stock options | −150,000 | 500,000 | D: show line 1 in the form | |||||
| Spissinger Allan Horst Chief Financial Officer | 2020-03-23 | Other disposition · stock options | −200,000 | 300,000 | D: show line 2 in the form | |||||
| Spissinger Allan Horst Chief Financial Officer | 2020-03-23 | Other disposition · stock options | −300,000 | 0 | D: show line 3 in the form |
Loading xslF345X03/primary_doc.xml…